Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific Cancels $230m Stent Deal After Regulators Erect Barriers To Acquisition is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific nixes $230M M.I.Tech acquisition - Fierce Biotech
Though that deal has now been terminated, Boston Scientific said it still plans to collaborate with M.I.Tech and has signed a new agreement that would give it a minority stake in the company ... Read More
Boston Scientific cancels $230M deal to buy Korean device maker
Boston Scientific is scrapping its $230 million plan to buy a majority stake in M.I. Tech, a Korean company that builds surgical tools. Instead, it will purchase a minority stake of around 10%. Read More
Boston Scientific offers $230M for Korean gastrointestinal, airway ...
Boston Scientific offers $230M for Korean maker of ... But it did not disclose how the acquisition deal might affect M.I.Tech’s ... “M.I.Tech is an innovator in non-vascular stent ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus